Couchbase CFO to Present at the Oppenheimer 21st Annual

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
87
Couchbase CFO to Present at the Oppenheimer 21st Annual Technology, Internet & Communications Conference in Boston

Mountain View, Calif., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Couchbase , creator of the world’s first Engagement Database, today announced that Couchbase CFO Greg Henry will present at the Oppenheimer 21st Annual Technology, Internet & Communications Conference taking place on August 7-8 at the Four Seasons Hotel in Boston, MA.

Couchbase’s presentation, which will focus on the company’s growth strategy, will take place from 1:05 p.m. – 1:40 p.m. ET on Tuesday, August 7th. On the same date, Henry will participate in a panel discussion around Next Gen Data Management from 10:25 a.m. – 11:00 a.m. ET.

The Oppenheimer Technology conference provides a broad look across the supply chain at existing and emerging technologies, and offers investors the opportunity to evaluate companies at the forefront of these innovations.

For additional information or to schedule a one-on-one meeting with Couchbase management, please contact IR@couchbase.com .

About Couchbase, Inc.

Couchbase's mission is to be the data platform that revolutionizes digital innovation. To make this possible, Couchbase created the world's first Engagement Database. Built on the most powerful NoSQL technology, the Couchbase Data Platform includes open source Couchbase Server and Couchbase Mobile. The platform provides unmatched agility and manageability -- as well as unparalleled performance at any scale -- to deliver ever-richer and ever more personalized customer experiences. For more information, visit www.couchbase.com.

Couchbase customers include industry leaders like Amadeus, AT&T, Carrefour, Cisco, Comcast, Concur, Disney, Dixons Carphone, DreamWorks Animation, eBay, Marriott, Neiman Marcus, Rakuten/Viber, Tesco, Tommy Hilfiger, Verizon, Wells Fargo, as well as hundreds of other household names. Couchbase investors include Accel Partners, Adams Street Partners, Ignition Partners, Mayfield Fund, North Bridge Venture Partners, Sorenson Capital, and WestSummit Capital.

Christina Rohall Knittel Couchbase 7752092461 christina.knittel@couchbase.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Exploring Advances in AI and Digital R&D Innovation by ICON plc

Updated Category News Views 227

Recent Developments in AI and Digital Innovation by ICON plc ICON plc, a globally recognized clinical research organization (NASDAQ: ICLR), has recently conducted an extensive survey exploring the integration of Artificial Intelligence (AI) and digital tools within clinical research. Engaging with over 100 professionals in the biotech and pharmaceutical industries across...

Continue Reading
Tesla's Self-Driving Claims Under Fire: Industry Reactions

Updated Category News Views 167

Tesla's License Suspension in California Recently, a court in California announced a significant development affecting Tesla Inc. (NASDAQ: TSLA). The court decided to suspend Tesla's license to sell vehicles for 30 days due to a lawsuit concerning misleading claims about the company's Full Self-Driving (FSD) technology. If Tesla does not adapt its policies within 90 days,...

Continue Reading
Sunnova Energy Faces Challenges Amid Revenue Declines in 2024

Updated Category News Views 384

Sunnova Energy Experiences Financial Struggles Sunnova Energy International Inc. (NOVA) has encountered a challenging period, with its shares trading lower in the premarket on Monday following a disappointing report detailing its fourth quarter and full-year financial results. The financial landscape for Sunnova shows a revenue of $224.127 million, which unfortunately...

Continue Reading
Kerusso's Important Contributions in Faith and Community Work

Updated Category News Views 133

Kerusso's Inspiring Charitable Contributions in 2025 Kerusso Activewear, a prominent Christian apparel and gift brand, has ended the year with a remarkable achievement of over $400,000 in charitable contributions. This reflects their steadfast commitment to enriching lives through faith-based approaches and generous support for individuals in need. Growing Demand for...

Continue Reading
Prelude Therapeutics and Incyte Join Forces for JAK2JH2 Inhibitor

Updated Category News Views 101

Prelude Therapeutics Partners with Incyte on JAK2V617F Program Incyte establishes exclusive option to acquire Prelude’s innovative programs These inhibitors have the potential to modify disease outcomes in patients with myeloproliferative neoplasms (MPNs) Prelude Therapeutics, a clinical-stage oncology company, has recently made headlines with an exciting announcement...

Continue Reading